SharonDavisLuikartMD

Oncology • Minneapolis, MN

Professor, Medicine, University of Minnesota Medical School, Minneapolis

Join to view full profile

Dr. Luikart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Luikart's full profile

Already have an account?

Office
1 Veterans Dr
111e
Minneapolis, MN 55417
Phone+1 612-467-4131

Fax+1 612-725-2149

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1983
Duke University HospitalResidency, Internal Medicine, 1976 - 1979
Duke University School of MedicineClass of 1975

Certifications & Licensure

MN State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

3 citations
Necrosis of uninvolved bone marrow following filgrastim administration in a patient with Burkitt lymphoma undergoing chemotherapy
Li Ding, Ajay Rawal, Sharon D Luikart, Punit Wadhwa
British Journal of Haematology. 2012-10-01
7 citations
Mactinin, a fragment of cytoskeletal α-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation
Sharon D Luikart, Angela Panoskaltsis-Mortari, Timothy Hinkel, Robert T. Perri, Kalpna Gupta
BMC Cell Biology. 2009-08-28
9 citations
Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice.
Sharon D Luikart, Brett K. Levay-Young, Tim Hinkel, Jeffry D. Shearer, Charles D. Mills
Wound Repair and Regeneration. 2006-03-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member